Rocket Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms.

CEO

Gaurav D. Shah

CEOGaurav D. Shah

Employees

299

Employees299

Headquarters

Cranbury, New Jersey

HeadquartersCranbury, New Jersey

Founded

1999

Founded1999

Employees

299

Employees299

RCKT Key Statistics

Market cap

314.59M

Market cap314.59M

Price-Earnings ratio

-1.10

Price-Earnings ratio-1.10

Dividend yield

—

Dividend yield—

Average volume

4.34M

Average volume4.34M

High today

$2.96

High today$2.96

Low today

$2.85

Low today$2.85

Open price

$2.91

Open price$2.91

Volume

1.75M

Volume1.75M

52 Week high

$26.98

52 Week high$26.98

52 Week low

$2.19

52 Week low$2.19

Analyst ratings

56%

of 18 ratings

Buy

55.6%

Hold

38.9%

Sell

5.6%

People also own

Based on the portfolios of people who own RCKT. This list is generated using Robinhood data, and it’s not a recommendation.